Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postpartum Severe Preeclampsia: 12-Hour Versus 24-Hour Magnesium Sulfate Maintenance
TCTR20230811008Phase 2Completed
- Sponsor
- Arifin Achmad Hospital
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of magnesium sulfate in preeclampsia (2 arms), sponsored by Arifin Achmad Hospital. Started Oct 2022; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
preeclampsia
Beyond the preview
Go deeper on TCTR20230811008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230811008.